| {"0": "Glycosaminoglycan degradation", "1": "Degradation pathway of sphingolipids including diseases", "2": "Sphingolipid metabolism in senescence", "3": "Ebola virus infection in host", "4": "Cholesterol metabolism with bloch and kandutschrussell pathways", "5": "Proteasome degradation", "6": "Nuclear receptors metapathway", "7": "Ferroptosis", "8": "Alzheimers disease", "9": "Alzheimers disease and mirna effects", "10": "Envelope proteins and their potential roles in edmd physiopathology", "11": "Regulation of actin cytoskeleton", "12": "Fragile x syndrome", "13": "Transsulfuration pathway", "14": "Pdgf pathway", "15": "Retinoblastoma gene in cancer", "16": "Metapathway biotransformation phase i and ii", "17": "Spinal cord injury", "18": "Hijack of ubiquitination by sarscov2", "19": "Transsulfuration and onecarbon metabolism", "20": "Physicochemical features and toxicityassociated pathways", "21": "G protein signaling pathways", "22": "Tgfbeta signaling pathway", "23": "Il18 signaling pathway", "24": "Ras signaling", "25": "Hepatocyte growth factor receptor signaling", "26": "Microtubule cytoskeleton regulation", "27": "Rac1pak1p38mmp2 pathway", "28": "Gastrin signaling pathway", "29": "Prolactin signaling pathway", "30": "Met in type 1 papillary renal cell carcinoma", "31": "Integrinmediated cell adhesion", "32": "Focal adhesion"} |